Counterpoint Mutual Funds’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,396
Closed -$801K 305
2025
Q1
$801K Buy
+7,396
New +$644K 0.11% 70
2024
Q4
Sell
-13,323
Closed -$1.31M 281
2024
Q3
$1.31M Buy
13,323
+10,485
+369% +$1.35M 0.25% 14
2024
Q2
$464K Buy
2,838
+76
+3% +$10.8K 0.11% 61
2024
Q1
$421K Buy
+2,762
New +$460K 0.1% 44

Other funds holding AGL

Counterpoint Mutual Funds's AGL Position: Q2 2025 in Review

Counterpoint Mutual Funds sold out of Agilon Health (AGL) in Q2 2025, closing a stake of 7,396 shares — an estimated $801K sold.

Counterpoint Mutual Funds first reported a position in AGL in Q1 2024 and held it in 4 quarters. The position peaked at $1.31M in Q3 2024. 205 funds tracked by Wall St. Rank hold AGL as of Q2 2025.

  • Counterpoint Mutual Funds reported no remaining Agilon Health position as of Q2 2025 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 7,396 Agilon Health shares in Q2 2025, an estimated $801K.
  • Counterpoint Mutual Funds first reported a position in Agilon Health in Q1 2024 and held it in 4 quarters.
  • Counterpoint Mutual Funds's Agilon Health position peaked at $1.31M in Q3 2024.
  • 205 funds tracked by Wall St. Rank held Agilon Health as of Q2 2025.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2025, filed 14 Jul 2025.